MedTrace Logo

Web-based Weight Loss Intervention

NCT03400696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63656

Last updated 2020-06-04

No results posted yet for this study

Summary

Excess weight is a major risk factor underlying leading causes of death globally, including cardiovascular disease, type 2 diabetes, and some cancers. Among participants assigned to the same lifestyle intervention arms in prior weight loss randomized controlled trials, large inter-individual differences in weight loss success have been observed, ranging from \>50lbs of weight loss to \>10lbs of weight gain. Both genetic and non-genetic factors underlying differential adherence and weight loss success are poorly understood.

Conditions

  • Overweight and Obesity

Interventions

BEHAVIORAL

Lower carbohydrate diet

Focused on limiting dietary carbohydrates, eating healthy fat and protein sources, and engaging in physical activity

BEHAVIORAL

Higher fiber diet

Focused on increasing dietary fiber, lowering fat intake from animal sources, and engaging in physical activity

BEHAVIORAL

Physical activity focused

Focused on aerobic and resistance exercise, while following dietary guidelines \<https://www.choosemyplate.gov\>

Sponsors & Collaborators

  • 23andMe, Inc.

    lead INDUSTRY

Principal Investigators

  • Geoffrey Benton, PhD · 23andMe, Inc.

  • Liana Del Gobbo, PhD · 23andMe, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-27
Primary Completion
2019-01-08
Completion
2019-04-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03400696 on ClinicalTrials.gov